Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study

Herbert Decaluwé, Christophe Dooms, Xavier Benoit D'Journo, Sergi Call, David Sanchez, Benedikt Haager, Roel Beelen, Volkan Kara, Thomas Klikovits, Clemens Aigner, Kurt Tournoy, Mahmood Zahin, Johnny Moons, Geoffrey Brioude, Juan Carlos Trujillo, Walter Klepetko, Akif Turna, Bernward Passlick, Laureano Molins, Ramon Rami-Porta, Pascal Thomas, Paul De Leyn

Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017
Journal Issue: December
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Herbert Decaluwé, Christophe Dooms, Xavier Benoit D'Journo, Sergi Call, David Sanchez, Benedikt Haager, Roel Beelen, Volkan Kara, Thomas Klikovits, Clemens Aigner, Kurt Tournoy, Mahmood Zahin, Johnny Moons, Geoffrey Brioude, Juan Carlos Trujillo, Walter Klepetko, Akif Turna, Bernward Passlick, Laureano Molins, Ramon Rami-Porta, Pascal Thomas, Paul De Leyn. Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study. Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
Source: Breathe, 14 (4) 342; 10.1183/20734735.027118
Year: 2018



Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial
Source: Eur Respir J 2007; 30: Suppl. 51, 240s
Year: 2007

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020

N-staging in CT N0-N1 non-small cell lung cancer patients: is there any place for mediastinoscopy?
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007


Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies
Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Year: 2004


Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

Routine neck ultrasound by respiratory physicians in the diagnosis and staging of patients with lung cancer and mediastinal lymphadenopathy: a prospective pilot study
Source: ERJ Open Res, 6 (1) 00180-2019; 10.1183/23120541.00180-2019
Year: 2020



Mode of early relapse in resectable I-IIIA NSCLC – prospective, controlled study
Source: Eur Respir J 2005; 26: Suppl. 49, 168s
Year: 2005

Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Endobronchial ultrasound for mediastinal restaging in non-small cell lung cancer
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Invasive versus minimally invasive staging for lung cancer: randomised trial
Source: Breathe 2011; 8: 79
Year: 2011

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020


Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003